Ubs Group Ag Valneva Se Put Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
13Shares Held
683KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$1.86 Million0.15% of portfolio
-
Wells Fargo & Company San Francisco, CA183KShares$959,4960.0% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR118KShares$618,3200.6% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$131,1150.1% of portfolio
-
Morgan Stanley New York, NY1.98KShares$10,3690.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $362M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...